A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 344 participants.

Also called NCT07438444

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 344 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07438444
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
India (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT07438444. Allocation not applicable; no masking; primary purpose treatment. Start 2026-02-27 (actual); primary completion 2027-07 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or Obesity
Condition
Diabetes Mellitus, Type 2
Condition
Obesity
Condition
Overweight
Intervention (Drug)
Tirzepatide
Lead sponsor
Eli Lilly and Company (class: industry)

Record details

Record id
cardio:ct-nct07438444
Content hash
246a279817de31c80e1855b569ac1a3a0656a3898f0083789d8b794867f7e44e